Medarex, Inc.
(NASDAQ:MEDX)|
4.42 -0.16 (-3.49%) Dec 04 - Close |
|
|
|
After-Hours 4.43 +0.01 (0.23%) Thu, 4 Dec 2008 7:40 PM
- Compare MEDX with:
- View: Line | Candlestick
Company Profile
Medarex, Inc.
707 State Road
Princeton, NJ 08540
United States - Map
Phone: (609) 430-2880
Fax: (609) 430-2850
Website: www.medarex.com
State of incorporation: New Jersey
CEO: Howard H. Pien
Employees: 500
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
We are a biopharmaceutical company
A biopharmaceutical company, focuses on the discovery, development and commercialization of human antibody-based therapeutic product candidates.
Recent news for MEDX
-
Medarex to Present at the RBC Capital Markets Healthcare Conference
PR Newswire - Yesterday at 7:00 ET
-
Three-Month, Updated FDA Decision Calendar
Seeking Alpha - Dec 01 at 5:23 ET
-
Ustekinumab PDUFA Could Kick Start Medarex Revival
Seeking Alpha - Nov 28 at 5:09 ET
-
PR Newswire - Nov 24 at 8:00 ET
-
Motley Fool - Nov 14 at 4:17 ET
-
Coverage initiated on Medarex by Merriman Curhan Ford
Briefing.com - Nov 14 at 12:40 ET
-
EDGAR Online Financials - Nov 08 at 9:04 ET
-
InPlay: Medarex receives milestone payment for investigational antibody targeting integrin receptors
Briefing.com - Nov 05 at 9:29 ET
-
Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
PR Newswire - Nov 05 at 6:00 ET
-
MEDAREX INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 04 at 4:41 ET